Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru
Phase of Trial: Phase III
Latest Information Update: 30 May 2014
At a glance
- Drugs CYD TDV (Primary) ; Yellow fever vaccine
- Indications Dengue; Yellow fever
- Focus Pharmacodynamics
- 01 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2013 Planned end date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 05 Feb 2013 Planned End Date changed from 1 Jan 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.